San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory conditions. The target applies to a range of potential indications, from ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

For H1 2025 Lloyd’s posted a £4.2bn ($5.6bn) H1 profit before tax which Tiernan called a “solid half-year performance, demonstrating strength and resilience”. This was down £700mn year on year, as ...

Battery cell layout can reduce risk, but it cannot compensate for deeper engineering and integration failures.

Yet, many medical affairs teams remain bound to traditional workflows. Linear processes and siloed functions are struggling ...

Shares are up 7% in trading today, after Geron announced a strategic restructuring to "position the company for long-term ...

Its victories may be few, its presence often shadowed, yet the Left's influence flows through every reform and welfare scheme ...

Recently, Risen Energy announced the signing of a 3 GWh energy storage system cooperation MOU with WEG, a leading Brazilian ...

RoviSys, a leading provider of comprehensive process automation, building automation, discrete manufacturing automation and digital transformation solutions has been recognized by CFE Media as a ...

The company has deep expertise in renewable energy, industrial energy efficiency, and smart grid technologies. In recent years, WEG has actively expanded into energy storage and integrated energy ...

Citius Oncology entered into an exclusive distribution agreement with Er-Kim to expand international access to Lymphir (denileukin diftitox-cxdl) in Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia ...